back conversion test [Regulatives / Guidelines]

posted by Thair Saleh – Jordan, 2024-07-01 11:42 (713 d 05:27 ago) – Posting: # 24050
Views: 2,663

dear Colleagues


in the case of metabolites, (unstable N-oxides or glucuronide metabolites, lactone-ring structures) found in the drug should always covered by the back conversion test, or there is a limit (2%, 5%, 10%) of the drug if the metabolite exceeds then should be covered.

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
151 visitors (0 registered, 151 guests [including 25 identified bots]).
Forum time: 17:09 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5